In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging.

Show reference:

https://doi.org/10.1212/WNL.0000000000209453